Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones

Barry L Carter, Gail Ardery, Barry L Carter, Gail Ardery

No abstract available

Keywords: multicenter trials; quality control; research; subject recruitment.

References

    1. Carter BL, Levy BT, Gryzlak B, Chrischilles EA, Vander Weg MW, Christensen AJ, James PA, Moss CA, Parker CP, Gums T, Finkelstein RJ, Xu Y, Dawson JD, Polgreen LA. A centralized cardiovascular risk service to improve guideline adherence in private primary care offices. Contemp Clin Trials. 2015;43:25–32.
    1. Carter BL, Coffey CS, Chrischilles EA, Ardery G, Ecklund D, Gryzlak B, Vander Weg MW, James PA, Christensen AJ, Parker CP, Gums T, Finkelstein RJ, Uribe L, Polgreen LA. A cluster‐randomized trial of a centralized clinical pharmacy cardiovascular risk service to improve guideline adherence. Pharmacotherapy. 2015;35:653–662.
    1. Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, Hartz AJ. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008;10:260–271.
    1. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, Chrischilles EA, Franciscus CL, Xu Y. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996–2002.
    1. Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, Egan B, Vander Weg MW, Chrischilles E, Vaughn T. Cluster‐randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8:235–243.
    1. Farris KB, Carter BL, Xu Y, Dawson JD, Shelsky C, Weetman DB, Kaboli PJ, James PA, Christensen AJ, Brooks JM. Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res. 2014;14:406.
    1. Carter BL, Clarke W, Ardery G, Weber CA, James PA, Vander Weg M, Chrischilles EA, Vaughn T, Egan BM. A cluster‐randomized effectiveness trial of a physician‐pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2010;3:418–423.
    1. Katzenbach JR, Smith DK. The Wisdom of Teams: Creating the High‐Performance Organization. New York, NY: HarperCollins; 2006.
    1. Dickerson LM, Kraus C, Kuo GM, Weber CA, Bazaldua OV, Tovar JM, Hume AL, Ives TJ, Gums JG, Carter BL. Formation of a primary care pharmacist practice‐based research network. Am J Health Syst Pharm. 2007;64:2044–2049.
    1. Maclaughlin EJ, Ardery G, Jackson EA, Ives TJ, Young RB, Fike DS, Carter BL. Institutional review board barriers and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a national multicenter practice‐based implementation trial. Pharmacotherapy. 2013;33:902–911.
    1. Anderegg MD, Gums TH, Uribe L, Coffey CS, James PA, Carter BL. Physician‐pharmacist collaborative management: narrowing the socioeconomic blood pressure gap. Hypertension. 2016;68:1314–1320.
    1. Gordon D, Taddei‐Peters W, Mascette A, Antman M, Kaufmann PG, Lauer MS. Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2013;369:1926–1934.
    1. Carter BL, Farris KB, Abramowitz PW, Weetman DB, Kaboli PJ, Dawson JD, James PA, Christensen AJ, Brooks JM. The Iowa Continuity of Care study: background and methods. Am J Health Syst Pharm. 2008;65:1631–1642.
    1. Carter BL, Coffey CS, Uribe L, James PA, Egan BM, Ardery G, Chrischilles EA, Ecklund D, Vander Weg M, Vaughn T. Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich). 2013;15:404–412.
    1. Demik DE, Vander Weg MW, Lundt ES, Coffey CS, Ardery G, Carter BL. Using theory to predict implementation of a physician‐pharmacist collaborative intervention within a practice‐based research network. Res Social Adm Pharm. 2013;9:719–730.
    1. Milchak JL, Carter BL, Ardery G, Black HR, Bakris GL, Jones DW, Kreiter CD. Development of explicit criteria to measure adherence to hypertension guidelines. J Hum Hypertens. 2006;20:426–433.
    1. Milchak JL, Carter BL, Ardery G, Dawson JD, Harmston M, Franciscus CL. Physician adherence to blood pressure guidelines and its effect on seniors. Pharmacotherapy. 2008;28:843–851.
    1. Milchak JL, Carter BL, Bakris GL, Black HR, Jones DW, Zillich AJ. Selection of explicit criteria for a JNC‐7 guideline adherence tool. Am J Hypertens. 2004;17:144A.
    1. Milchak JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension. 2004;44:602–608.
    1. Ardery G, Carter BL, Milchak JL, Bergus GR, Dawson JD, James PA, Franciscus C, Kim Y. Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens (Greenwich). 2007;9:113–119.
    1. Carter BL, Doucette WR, Franciscus CL, Ardery G, Kluesner KM, Chrischilles EA. Deterioration of blood pressure control after discontinuation of a physician‐pharmacist collaborative intervention. Pharmacotherapy. 2010;30:228–235.
    1. Criswell TJ, Weber CA, Xu Y, Carter BL. Effect of self‐efficacy and social support on adherence to antihypertensive drugs. Pharmacotherapy. 2010;30:432–441.
    1. Wentzlaff DM, Carter BL, Ardery G, Franciscus CL, Doucette WR, Chrischilles EA, Rosenkrans KA, Buys LM. Sustained blood pressure control following discontinuation of a pharmacist intervention. J Clin Hypertens (Greenwich). 2011;13:431–437.
    1. Israel EN, Farley TM, Farris KB, Carter BL. Underutilization of cardiovascular medications: effect of a continuity‐of‐care program. Am J Health Syst Pharm. 2013;70:1592–1600.
    1. Von Muenster SJ, Carter BL, Weber CA, Ernst ME, Milchak JL, Steffensmeier JJ, Xu Y. Description of pharmacist interventions during physician‐pharmacist co‐management of hypertension. Pharm World Sci. 2008;30:128–135.
    1. Anderegg SV, Demik DE, Carter BL, Dawson JD, Farris K, Shelsky C, Kaboli P. Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care. Pharmacotherapy. 2013;33:11–21.
    1. Farley TM, Shelsky C, Powell S, Farris KB, Carter BL. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014;36:430–437.
    1. Gums TH, Carter BL, Milavetz G, Buys L, Rosenkrans K, Uribe L, Coffey C, MacLaughlin EJ, Young RB, Ables AZ, Patel‐Shor N, Wisniewski A. Physician‐pharmacist collaborative management of asthma in primary care. Pharmacotherapy. 2014;34:1033–1042.
    1. Gums TH, Uribe L, Vander Weg MW, James P, Coffey C, Carter BL. Pharmacist intervention for blood pressure control: medication intensification and adherence. J Am Soc Hypertens. 2015;9:569–578.
    1. Chen Z, Ernst ME, Ardery G, Xu Y, Carter BL. Physician‐pharmacist co‐management and 24‐hour blood pressure control. J Clin Hypertens (Greenwich). 2013;15:337–343.
    1. Weber CA, Leloux MR, Carter BL, Farris KB, Xu Y. Reduction in adverse symptoms as blood pressure becomes controlled. Pharmacotherapy. 2008;28:1104–1114.
    1. Kulchaitanaroaj P, Brooks JM, Ardery G, Newman D, Carter BL. Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control. Pharmacotherapy. 2012;32:772–780.
    1. Polgreen LA, Han J, Carter BL, Ardery GP, Coffey CS, Chrischilles EA, James PA. Cost‐effectiveness of a physician‐pharmacist collaboration intervention to improve blood pressure control. Hypertension. 2015;66:1145–1151.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere